Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD.

MLA

Fadda, Giulia, et al. “Myelitis Features and Outcomes in CNS Demyelinating Disorders: Comparison between Multiple Sclerosis, MOGAD, and AQP4-IgG-Positive NMOSD.” Frontiers in Neurology, vol. 13, Nov. 2022, pp. 1–16. EBSCOhost, https://doi.org/10.3389/fneur.2022.1011579.

APA

Fadda, G., Flanagan, E. P., Cacciaguerra, L., Jitprapaikulsan, J., Solla, P., Zara, P., & Sechi, E. (2022). Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. Frontiers in Neurology, 13, 1–16. https://doi.org/10.3389/fneur.2022.1011579

Chicago

Fadda, Giulia, Eoin P. Flanagan, Laura Cacciaguerra, Jiraporn Jitprapaikulsan, Paolo Solla, Pietro Zara, and Elia Sechi. 2022. “Myelitis Features and Outcomes in CNS Demyelinating Disorders: Comparison between Multiple Sclerosis, MOGAD, and AQP4-IgG-Positive NMOSD.” Frontiers in Neurology 13 (November): 1–16. doi:10.3389/fneur.2022.1011579.